Under construction – not a live service
Sign in
Not yet taking people in United KingdomPhase 2

Comparing two wound dressings after surgery to remove sarcoma

Compares standard absorbent dressings with negative pressure dressings in people having sarcoma surgery.

Plain-language title generated from the registry record
Registry title: Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing

Key facts

Where
Glasgow, United KingdomSee the site
Phase
Phase 2

Where in United Kingdom

  • Glasgow Royal InfirmaryGlasgow, United KingdomNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
NHS Greater Glasgow and Clyde
Trial code
NCT07048184
Record updated
9 July 2025
Original description
To compare the differences in clinical outcomes and health economics between standard absorbent dressings versus Negative Pressure Wound Therapy dressings following the surgical resection of sarcoma tumours.Read full original descriptionShow less

Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing: a Randomised Phase II Trial

To compare the differences in clinical outcomes and health economics between standard absorbent dressings versus Negative Pressure Wound Therapy dressings following the surgical resection of sarcoma tumours.

Inclusion: Sarcoma of the upper/lower limb or torso requiring wide local excision, planned marginal excision or amputation; Able to provide informed consent; Aged 16 years or over; Able, and willing, to adhere to scheduled trial procedures and visit schedule.

Exclusion: Previous surgery to planned surgical field; Contra-indication to surgical excision of the tumour; Post-radiation sarcoma; Disseminated malignancy on pre-op radiological imaging; Allergy to adhesive dressing; Subjects who, in the opinion of the PI, will be unable to comply with follow-up.

ClinicalTrials.gov NCT07048184